Phenotypic flexibility as a measure of health: the optimal nutritional stress response test

Johanna H M Stroeve, Herman van Wietmarschen, Bas H A Kremer, Ben van Ommen, Suzan Wopereis, Johanna H M Stroeve, Herman van Wietmarschen, Bas H A Kremer, Ben van Ommen, Suzan Wopereis

Abstract

Nutrition research is struggling to demonstrate beneficial health effects, since nutritional effects are often subtle and long term. Health has been redefined as the ability of our body to cope with daily-life challenges. Physiology acts as a well-orchestrated machinery to adapt to the continuously changing environment. We term this adaptive capacity "phenotypic flexibility." The phenotypic flexibility concept implies that health can be measured by the ability to adapt to conditions of temporary stress, such as physical exercise, infections or mental stress, in a healthy manner. This may offer a more sensitive way to assess changes in health status of healthy subjects. Here, we performed a systematic review of 61 studies applying different nutritional stress tests to quantify health and nutritional health effects, with the objective to define an optimal nutritional stress test that has the potential to be adopted as the golden standard in nutrition research. To acknowledge the multi-target role of nutrition, a relevant subset of 50 processes that govern optimal health, with high relevance to diet, was used to define phenotypic flexibility. Subsequently, we assessed the response of biomarkers related to this subset of processes to the different challenge tests. Based on the obtained insights, we propose a nutritional stress test composed of a high-fat, high-caloric drink, containing 60 g palm olein, 75 g glucose and 20 g dairy protein in a total volume of 400 ml. The use of such a standardized nutritional challenge test in intervention studies is expected to demonstrate subtle improvements of phenotypic flexibility, thereby enabling substantiation of nutritional health effects.

Figures

Fig. 1
Fig. 1
Physiological processes involved in phenotypic flexibility. Thirty-five different physiological processes that may be influenced by food and nutrition have been defined. The optimal nutritional stress challenge should trigger all these physiological processes, so that it allows the broad quantification of nutritional health effects
Fig. 2
Fig. 2
Graphical representation of a single-marker response profile during homeostasis and upon challenge test before and after intervention. The challenge test evokes a response in concentration of a biomarker that is representative of a physiological system of interest which returns to homeostatic levels after a period of time. The intervention should ideally lead to an improved challenge response in terms of amplitude and duration
Fig. 3
Fig. 3
Ratio of carbohydrate, fat and protein in combination challenge tests used in reported studies. The studies are organized from high carbohydrate content on the left to low carbohydrate content on the right (1 Esposito and Nappo, 2 Zwirska-Korczala, 3 Ramos-Roman, 4 Casas-Agustench, 5 Phillips, 6 Scheffer, 7 Wopereis, 8 Pellis, 9 Krug, 10 Thomsen, 11 Coutinho, 12 Derosa, 13 Cheng, 14 Mortensen, 15 Saxena, 16 Mahdu, 17 Iraklianou)

References

    1. Ahuja KDK, Robertson IK, Ball MJ. Acute effects of food on postprandial blood pressure and measures of arterial stiffness in healthy humans. Am J Clin Nutr. 2009;90:298–303. doi: 10.3945/ajcn.2009.27771.
    1. Askari AA, Thomson S, Edin ML, Lih FB, Zeldin DC, Bishop-Bailey D. Basal and inducible anti-inflammatory epoxygenase activity in endothelial cells. Biochem Biophys Res Commun. 2014;446:633–637. doi: 10.1016/j.bbrc.2014.03.020.
    1. Bae J, Bassenge E, Kim K, Kim Y, Kim K, Lee H, Moon K, Lee M, Park K, Schwemmer M. Postprandial hypertriglyceridemia impairs endothelial function by enhanced oxidant stress. Atherosclerosis. 2001;155:517–523. doi: 10.1016/S0021-9150(00)00601-8.
    1. Bartoli E, Fra GP, Schianca GPC. The oral glucose tolerance test (OGTT) revisited. Eur J Intern Med. 2011;22:8–12. doi: 10.1016/j.ejim.2010.07.008.
    1. Blaak EE, Hul G, Verdich C, Stich V, Martinez A, Petersen M, Feskens EFM, Patel K, Oppert JM, Barbe P, Toubro S, Anderson I, Polak J, Astrup A, Macdonald IA, Langin D, Holst C, Sørensen TI, Saris WHM. Fat oxidation before and after a high fat load in the obese insulin-resistant state. J Clin Endocrinol Metab. 2006;91:1462–1469. doi: 10.1210/jc.2005-1598.
    1. Blackburn P, Despres JP, Lamarche B, Tremblay A, Bergeron J, Lemieux I, Couillard C. Postprandial variations of plasma inflammatory markers in abdominally obese men. Obesity (Silver Spring) 2006;14:1747–1754. doi: 10.1038/oby.2006.201.
    1. Blix G. Studies in diabetic lipemia. Lund: Berlingska Boktryckeriet; 1925.
    1. Bloor WR. Fat assimilation. J Biol Chem. 1916;24:447–460.
    1. Bosch JP, Lauer A, Glabman S. Short-term protein loading in assessment of patients with renal disease. Am J Med. 1984;77:873–879. doi: 10.1016/0002-9343(84)90529-1.
    1. Brufau G, Bahr MJ, Staels B, Claudel T, Ockenga J, Böker KHW, Murphy EJ, Prado K, Stellaard F, Manns MP, Kuipers F, Tietge UJF (2010) Plasma bile acids are not associated with energy metabolism in humans. Nutr Metab 7:73
    1. Brun G (1940) Changes in the lipid contents of serum in patients with manic-depressive psychosis, 1st edn. Munksgaard, Copenhagen, Denmark
    1. Campbell CG, Brown BD, Dufner D, Thorland WG. Effects of soy or milk protein during a high-fat feeding challenge on oxidative stress, inflammation, and lipids in healthy men. Lipids. 2006;41:257–265. doi: 10.1007/s11745-006-5095-5.
    1. Casas-Agustench P, López-Uriarte P, Bulló M, Ros E, Gómez-Flores A, Salas-Salvadó J. Acute effects of three high-fat meals with different fat saturations on energy expenditure, substrate oxidation and satiety. Clin Nutr. 2009;28:39–45. doi: 10.1016/j.clnu.2008.10.008.
    1. Ceriello A, Quagliaro L, Piconi L, Assaloni R, Da Ros R, Maier A, Esposito K, Giugliano D. Effect of postprandial hypertriglyceridemia and hyperglycemia on circulating adhesion molecules and oxidative stress generation and the possible role of simvastatin treatment. Diabetes. 2004;53:701–710. doi: 10.2337/diabetes.53.3.701.
    1. Cheng Y, Kao W-L, Mitchell BD, Sharrett AR, Ryan KA, Vogel RA, Shuldiner AR, Pollin TI. Genetic effects on postprandial variations of inflammatory markers in healthy individuals. Obesity. 2010;18:1417–1422. doi: 10.1038/oby.2009.416.
    1. Coutinho ER, Macedo GM, Campos FS, Bandeira FA. Changes in HDL cholesterol and in the inflammatory markers of atherogenesis after an oral fat load in type-2 diabetic patients and normal individuals. Metab Syndr Relat Disord. 2008;6:153–157. doi: 10.1089/met.2007.0032.
    1. Cruz-Teno C, Pérez-Martínez P, Delgado-Lista J, Yubero-Serrano EM, García-Ríos A, Marín C, Gómez P, Jiménez-Gómez Y, Camargo A, Rodríguez-Cantalejo F, Malagón MM, Pérez-Jiménez F, Roche HM, López-Miranda J. Dietary fat modifies the postprandial inflammatory state in subjects with metabolic syndrome: the LIPGENE study. Mol Nutr Food Res. 2012;56:854–865. doi: 10.1002/mnfr.201200096.
    1. Dekker MJ, Wright AJ, Mazurak VC, Graham TE, Marangoni AG, Robinson LE. New oral fat tolerance tests feature tailoring of the polyunsaturated/saturated fatty acid ratio to elicit a specific postprandial response. Appl Physiol Nutr Metab. 2007;32:1073–1081. doi: 10.1139/H07-101.
    1. Dekker MJ, Wright AJ, Mazurak VC, Marangoni AG, Rush JW, Graham TE, Robinson LE. Fasting triacylglycerol status, but not polyunsaturated/saturated fatty acid ratio, influences the postprandial response to a series of oral fat tolerance tests. J Nutr Biochem. 2009;20:694–704. doi: 10.1016/j.jnutbio.2008.06.012.
    1. Derosa G, Ferrari I, D’Angelo A, Salvadeo SAT, Fogari E, Gravina A, Mereu R, Palumbo I, Maffioli P, Randazzo S, Cicero AFG. Effects of a standardized oral fat load on vascular remodelling markers in healthy subjects. Microvasc Res. 2010;80:110–115. doi: 10.1016/j.mvr.2010.03.012.
    1. Esposito K, Nappo F, Giugliano F, Di Palo C, Ciotola M, Barbieri M, Paolisso G, Giugliano D. Meal modulation of circulating interleukin 18 and adiponectin concentrations in healthy subjects and in patients with type 2 diabetes mellitus. Am J Clin Nutr. 2003;78:1135–1140.
    1. Esser D, Oosterink E, op ‘t Roodt J, Henry RMA, Stehouwer CDA, Müller M, Afman LA (2013a) Vascular and inflammatory high fat meal responses in young healthy men; a discriminative role of IL-8 observed in a randomized trial. PLoS One 8:e53474
    1. Esser D, van Dijk SJ, Oosterink E, Müller M, Afman LA. A high-fat SFA, MUFA, or n3 PUFA challenge affects the vascular response and initiates an activated state of cellular adherence in lean and obese middle-aged men. J Nutr. 2013;143:843–851. doi: 10.3945/jn.113.174540.
    1. Esser D, Mars M, Oosterink E, Stalmach A, Müller M, Afman LA. Dark chocolate consumption improves leukocyte adhesion factors and vascular function in overweight men. FASEB J. 2014;28:1464–1473. doi: 10.1096/fj.13-239384.
    1. Fernandes J, van de Kamer JH. Hexose and protein tolerance tests in children with liver glycogenosis caused by a deficiency of the debranching enzyme system. Pediatrics. 1968;41:935–944.
    1. Garcia-Rizo C, Fernandez-Egea E, Miller BJ, Oliveira C, Justicia A, Griffith JK, Heaphy CM, Bernardo M, Kirkpatrick B. Abnormal glucose tolerance, white blood cell count, and telomere length in newly diagnosed, antidepressant-naïve patients with depression. Brain Behav Immun. 2013;28:49–53. doi: 10.1016/j.bbi.2012.11.009.
    1. Gault VA, McClean PL, Cassidy RS, Irwin N, Flatt PR. Chemical gastric inhibitory polypeptide receptor antagonism protects against obesity, insulin resistance, glucose intolerance and associated disturbances in mice fed high-fat and cafeteria diets. Diabetologia. 2007;50:1752–1762. doi: 10.1007/s00125-007-0710-4.
    1. Giordano RM, Newman JW, Pedersen TL, Ramos MI, Stebbins CL. Effects of dynamic exercise on plasma arachidonic acid epoxides and diols in human volunteers. Int J Sport Nutr Exerc Metab. 2011;21:471–479.
    1. Gosmanov AR, Smiley DD, Robalino G, Siquiera J, Khan B, Le N, Patel RS, Quyyumi AA, Peng L, Kitabchi AE, Umpierrez GE. Effects of oral and intravenous fat load on blood pressure, endothelial function, sympathetic activity, and oxidative stress in obese healthy subjects. Am J Physiol Endocrinol Metab. 2010;299:E953–E958. doi: 10.1152/ajpendo.00469.2010.
    1. Hansotia T, Maida A, Flock G, Yamada Y, Tsukiyama K, Seino Y, Drucker DJ. Extrapancreatic incretin receptors modulate glucose homeostasis, body weight, and energy expenditure. J Clin Invest. 2007;117:143–152. doi: 10.1172/JCI25483.
    1. Harte AL, Varma MC, Tripathi G, Mcgee KC, Al-Daghri NM, Al-Attas OS, Sabico S, O’Hare JP, Ceriello A, Saravanan P, Kumar S, Mcternan PG. High fat intake leads to acute postprandial exposure to circulating endotoxin in type 2 diabetic subjects. Diabetes Care. 2012;35:375–382. doi: 10.2337/dc11-1593.
    1. Hiller A, Linder GC, Lundsgaard C, Van Slyke DD. Fat metabolism in nephritis. J Exp Med. 1924;39:931–955. doi: 10.1084/jem.39.6.931.
    1. Huber M, Knottnerus JA, Green L, van der Horst H, Jadad AR, Kromhout D, Leonard B, Lorig K, Loureiro MI, van der Meer JW, Schnabel P, Smith R, van Weel C, Smid H. How should we define health? BMJ. 2011;343:d4163. doi: 10.1136/bmj.d4163.
    1. Iraklianou S, Melidonis A, Tournis S, Konstandelou E, Tsatsoulis A, Elissaf M, Sideris D. Postprandial leptin responses after an oral fat tolerance test: differences in type 2 diabetes. Diabetes Care. 2001;24:1299–1301. doi: 10.2337/diacare.24.7.1299-a.
    1. Jellema A, Plat J, Mensink RP. Weight reduction, but not a moderate intake of fish oil, lowers concentrations of inflammatory markers and PAI-1 antigen in obese men during the fasting and postprandial state. Eur J Clin Invest. 2004;34:766–773. doi: 10.1111/j.1365-2362.2004.01414.x.
    1. Kim S, Nian C, McIntosh CHS. Resistin is a key mediator of glucose-dependent insulinotropic polypeptide (GIP) stimulation of lipoprotein lipase (LPL) activity in adipocytes. J Biol Chem. 2007;282:34139–34147. doi: 10.1074/jbc.M704896200.
    1. Kirkpatrick B, Fernandez-Egea E, Garcia-Rizo C, Bernardo M. Differences in glucose tolerance between deficit and nondeficit schizophrenia. Schizophr Res. 2009;107:122–127. doi: 10.1016/j.schres.2008.09.023.
    1. Krug S, Kastenmüller G, Stückler F, Rist MJ, Skurk T, Sailer M, Raffler J, Römisch-Margl W, Adamski J, Prehn C, Frank T, Engel K, Hofmann T, Luy B, Zimmermann R, Moritz F, Schmitt-Kopplin P, Krumsiek J, Kremer W, Huber F, Oeh U, Theis FJ, Szymczak W, Hauner H, Suhre K, Daniel H. The dynamic range of the human metabolome revealed by challenges. FASEB J. 2012;26:2607–2619. doi: 10.1096/fj.11-198093.
    1. Lundman P, Boquist S, Samnegård A, Bennermo M, Held C, Ericsson C, Silveira A, Hamsten A, Tornvall P. A high-fat meal is accompanied by increased plasma interleukin-6 concentrations. Nutr Metab Cardiovasc Dis. 2007;17:195–202. doi: 10.1016/j.numecd.2005.11.009.
    1. MacEneaney OJ, Harrison M, O’Gorman DJ, Pankratieva EV, O’Connor PL, Moyna NM. Effect of prior exercise on postprandial lipemia and markers of inflammation and endothelial activation in normal weight and overweight adolescent boys. Eur J Appl Physiol. 2009;106:721–729. doi: 10.1007/s00421-009-1073-y.
    1. Madec S, Corretti V, Santini E, Ferrannini E, Solini A. Effect of a fatty meal on inflammatory markers in healthy volunteers with a family history of type 2 diabetes. Br J Nutr. 2011;106:364–368. doi: 10.1017/S0007114511000286.
    1. Madhu SV, Mittal V, Krishna Ram B, Srivastava DK. Postprandial lipid abnormalities in type 2 diabetes mellitus. J Assoc Physicians India. 2005;53:1043–1046.
    1. Madhu SV, Kant S, Srivastava S, Kant R, Sharma SB, Bhadoria DP. Postprandial lipaemia in patients with impaired fasting glucose, impaired glucose tolerance and diabetes mellitus. Diabetes Res Clin Pract. 2008;80:380–385. doi: 10.1016/j.diabres.2008.01.016.
    1. Manning PJ, Sutherland WHF, McGrath MM, De Jong SA, Walker RJ, Williams MJA. Postprandial cytokine concentrations and meal composition in obese and lean women. Obesity. 2008;16:2046–2052. doi: 10.1038/oby.2008.334.
    1. Matysik S, Martin J, Bala M, Scherer M, Schäffler A, Schmitz G. Bile acid signaling after an oral glucose tolerance test. Chem Phys Lipids. 2011;164:525–529. doi: 10.1016/j.chemphyslip.2011.05.003.
    1. McClean PL, Irwin N, Cassidy RS, Holst JJ, Gault VA, Flatt PR. GIP receptor antagonism reverses obesity, insulin resistance, and associated metabolic disturbances induced in mice by prolonged consumption of high-fat diet. Am J Physiol Endocrinol Metab. 2007;293:E1746–E1755. doi: 10.1152/ajpendo.00460.2007.
    1. Mekki N, Charbonnier M, Borel P, Leonardi J, Juhel C, Portugal H, Lairon D. Butter differs from olive oil and sunflower oil in its effects on postprandial lipemia and triacylglycerol-rich lipoproteins after single mixed meals in healthy young men. J Nutr. 2002;132:3642–3649.
    1. Metzig AM, Schwarzenberg SJ, Fox CK, Deering MM, Nathan BM, Kelly AS. Postprandial endothelial function, inflammation, and oxidative stress in obese children and adolescents. Obesity. 2011;19:1279–1283. doi: 10.1038/oby.2010.318.
    1. Musso G, Gambino R, Pacini G, De Michieli F, Cassader M. Prolonged saturated fat-induced, glucose-dependent insulinotropic polypeptide elevation is associated with adipokine imbalance and liver injury in nonalcoholic steatohepatitis: dysregulated enteroadipocyte axis as a novel feature of fatty liver. Am J Clin Nutr. 2009;89:558–567. doi: 10.3945/ajcn.2008.26720.
    1. Nagashima H, Endo M. Pitavastatin prevents postprandial endothelial dysfunction via reduction of the serum triglyceride level in obese male subjects. Heart Vessels. 2011;26:428–434. doi: 10.1007/s00380-010-0071-7.
    1. Nakatsuji H, Kishida K, Kitamura T, Nakajima C, Funahashi T, Shimomura I. Dysregulation of glucose, insulin, triglyceride, blood pressure, and oxidative stress after an oral glucose tolerance test in men with abdominal obesity. Metab Clin Exp. 2010;59:520–526. doi: 10.1016/j.metabol.2009.08.013.
    1. Nappo F, Esposito K, Cioffi M, Giugliano G, Molinari AM, Paolisso G, Marfella R, Giugliano D. Postprandial endothelial activation in healthy subjects and in type 2 diabetic patients: role of fat and carbohydrate meals. J Am Coll Cardiol. 2002;39:1145–1150. doi: 10.1016/S0735-1097(02)01741-2.
    1. Neumann A. Uber ultramikroskopische Blutuntersuchungen zur Zeit der Fettresorption bei Gesunden und Kranken. Wien Clin Wschr. 1907;20:851.
    1. Newens KJ, Thompson AK, Jackson KG, Wright J, Williams CM. Acute effects of elevated NEFA on vascular function: a comparison of SFA and MUFA. Br J Nutr. 2011;105:1343–1351. doi: 10.1017/S0007114510004976.
    1. Oakley FR, Sanders TAB, Miller GJ. Postprandial effects of an oleic acid-rich oil compared with butter on clotting factor VII and fibrinolysis in healthy men. Am J Clin Nutr. 1998;68:1202–1207.
    1. Ogita K, Ai M, Tanaka A, Ito Y, Hirano T, Yoshino G, Shimokado K. Serum concentration of small dense low-density lipoprotein-cholesterol during oral glucose tolerance test and oral fat tolerance test. Clin Chim Acta. 2008;387:36–41. doi: 10.1016/j.cca.2007.08.016.
    1. Peairs AD, Rankin JW, Lee Y (2011) Effects of acute ingestion of different fats on oxidative stress and inflammation in overweight and obese adults. Nutr J 10:122
    1. Pellis L, van Erk MJ, van Ommen B, Bakker GC, Hendriks HF, Cnubben NH, Kleemann R, van Someren EP, Bobeldijk I, Rubingh CM, Wopereis S. Plasma metabolomics and proteomics profiling after a postprandial challenge reveal subtle diet effects on human metabolic status. Metabolomics. 2012;8:347–359. doi: 10.1007/s11306-011-0320-5.
    1. Phillips LK, Peake JM, Zhang X, Hickman IJ, Kolade O, Sacre JW, Huang BE, Simpson P, Li SH, Whitehead JP, Sharman JE, Martin JH, Prins JB. The effect of a high-fat meal on postprandial arterial stiffness in men with obesity and type 2 diabetes. J Clin Endocrinol Metab. 2010;95:4455–4459. doi: 10.1210/jc.2010-0413.
    1. Piers LS, Walker KZ, Stoney RM, Soares MJ, O’Dea K. The influence of the type of dietary fat on postprandial fat oxidation rates: monounsaturated (olive oil) vs saturated fat (cream) Int J Obes. 2002;26:814–821. doi: 10.1038/sj.ijo.0801993.
    1. Poppitt SD, Keogh GF, Lithander FE, Wang Y, Mulvey TB, Chan Y, McArdle BH, Cooper GJS. Postprandial response of adiponectin, interleukin-6, tumor necrosis factor-α, and C-reactive protein to a high-fat dietary load. Nutrition. 2008;24:322–329. doi: 10.1016/j.nut.2007.12.012.
    1. Potter M, Hammond JW, Sim K, Green AK, Wilcken B. Ornithine carbamoyltransferase deficiency: improved sensitivity of testing for protein tolerance in the diagnosis of heterozygotes. J Inherit Metab Dis. 2001;24:5–14. doi: 10.1023/A:1005682017337.
    1. Ramos-Roman MA, Sweetman L, Valdez MJ, Parks EJ. Postprandial changes in plasma acylcarnitine concentrations as markers of fatty acid flux in overweight and obesity. Metab Clin Exp. 2012;61:202–212. doi: 10.1016/j.metabol.2011.06.008.
    1. Rhee EP, Cheng S, Larson MG, Walford GA, Lewis GD, McCabe E, Yang E, Farrell L, Fox CS, O’Donnell CJ, Carr SA, Vasan RS, Florez JC, Clish CB, Wang TJ, Gerszten RE. Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans. J Clin Invest. 2011;121:1402–1411. doi: 10.1172/JCI44442.
    1. Saxena R, Madhu SV, Shukla R, Prabhu KM, Gambhir JK. Postprandial hypertriglyceridemia and oxidative stress in patients of type 2 diabetes mellitus with macrovascular complications. Clin Chim Acta. 2005;359:101–108. doi: 10.1016/j.cccn.2005.03.036.
    1. Scheffer PG, Tushuizen ME, Vermue HPA, Schindhelm RK, Rustemeijer C, Diamant M. Effect of three consecutive meals on the physicochemical properties of HDL and LDL in individuals with the metabolic syndrome and patients with type 2 diabetes. Eur J Clin Nutr. 2011;65:1242–1249. doi: 10.1038/ejcn.2011.114.
    1. Shaham O, Wei R, Wang TJ, Ricciardi C, Lewis GD, Vasan RS, Carr SA, Thadhani R, Gerszten RE, Mootha VK (2008) Metabolic profiling of the human response to a glucose challenge reveals distinct axes of insulin sensitivity. Mol Syst Biol 4:214
    1. Shearer GC, Newman JW. Impact of circulating esterified eicosanoids and other oxylipins on endothelial function. Curr Atheroscler Rep. 2009;11:403–410. doi: 10.1007/s11883-009-0061-3.
    1. Skurk T, Rubio-Aliaga I, Stamfort A, Hauner H, Daniel H. New metabolic interdependencies revealed by plasma metabolite profiling after two dietary challenges. Metabolomics. 2011;7:388–399. doi: 10.1007/s11306-010-0258-z.
    1. Soares MJ, Cummings SJ, Mamo JCL, Kenrick M, Piers LS. The acute effects of olive oil v. cream on postprandial thermogenesis and substrate oxidation in postmenopausal women. Br J Nutr. 2004;91:245–252. doi: 10.1079/BJN20031047.
    1. Spallarossa P, Garibaldi S, Barisione C, Ghigliotti G, Altieri P, Tracchi I, Fabbi P, Barsotti A, Brunelli C. Postprandial serum induces apoptosis in endothelial cells: role of polymorphonuclear-derived myeloperoxidase and metalloproteinase-9 activity. Atherosclerosis. 2008;198:458–467. doi: 10.1016/j.atherosclerosis.2007.11.030.
    1. Spégel P, Danielsson APH, Bacos K, Nagorny CLF, Moritz T, Mulder H, Filipsson K. Metabolomic analysis of a human oral glucose tolerance test reveals fatty acids as reliable indicators of regulated metabolism. Metabolomics. 2010;6:56–66. doi: 10.1007/s11306-009-0177-z.
    1. Strassburg K, Esser D, Vreeken RJ, Hankemeier T, Müller M, van Duynhoven J, van Golde J, van Dijk SJ, Afman LA, Jacobs DM. Postprandial fatty acid specific changes in circulating oxylipins in lean and obese men after high-fat challenge tests. Mol Nutr Food Res. 2014;58:591–600. doi: 10.1002/mnfr.201300321.
    1. Tamburrelli C, Gianfagna F, D’Imperio M, De Curtis A, Rotilio D, Iacoviello L, de Gaetano G, Donati MB, Cerletti C. Postprandial cell inflammatory response to a standardised fatty meal in subjects at different degree of cardiovascular risk. Thromb Haemost. 2012;107:530–537. doi: 10.1160/TH11-09-0674.
    1. Thomsen C, Storm H, Holst JJ, Hermansen K. Differential effects of saturated and monounsaturated fats on postprandial lipemia and glucagon-like peptide 1 responses in patients with type 2 diabetes. Am J Clin Nutr. 2003;77:605–611.
    1. Tiwari SC, Mahajan S, Gupta U. Protein tolerance test. J Indian Acad Clin Med. 2005;6:198–200.
    1. Tulk HMF, Robinson LE. Modifying the n-6/n-3 polyunsaturated fatty acid ratio of a high-saturated fat challenge does not acutely attenuate postprandial changes in inflammatory markers in men with metabolic syndrome. Metab Clin Exp. 2009;58:1709–1716. doi: 10.1016/j.metabol.2009.05.031.
    1. Umpaichitra V, Banerji MA, Castells S. Postprandial hyperlipidemia after a fat loading test in minority adolescents with type 2 diabetes mellitus and obesity. J Pediatr Endocrinol Metab. 2004;17:853–864. doi: 10.1515/JPEM.2004.17.6.853.
    1. van Dijk SJ, Mensink M, Esser D, Feskens EJM, Müller M, Afman LA (2012) Responses to high-fat challenges varying in fat type in subjects with different metabolic risk phenotypes: a randomized trial. PLoS One 7:e41388
    1. van Ommen B, van der Greef J, Ordovas JM, Daniel H (2014) Phenotypic flexibility as key factor in the human nutrition and health relationship. Genes Nutr 9:423
    1. van Oostrom AJ, Sijmonsma TP, Verseyden C, Jansen EH, de Koning EJ, Rabelink TJ, Castro Cabezas M. Postprandial recruitment of neutrophils may contribute to endothelial dysfunction. J Lipid Res. 2003;44:576–583. doi: 10.1194/jlr.M200419-JLR200.
    1. Van Oostrom AJHHM, Sijmonsma TP, Rabelink TJ, Van Asbeck BS, Castro Cabezas M. Postprandial leukocyte increase in healthy subjects. Metab Clin Exp. 2003;52:199–202. doi: 10.1053/meta.2003.50037.
    1. van Oostrom AJ, Rabelink TJ, Verseyden C, Sijmonsma TP, Plokker HW, De Jaegere PP, Cabezas MC. Activation of leukocytes by postprandial lipemia in healthy volunteers. Atherosclerosis. 2004;177:175–182. doi: 10.1016/j.atherosclerosis.2004.07.004.
    1. Wang L, Gill R, Pedersen TL, Higgins LJ, Newman JW, Rutledge JC. Triglyceride-rich lipoprotein lipolysis releases neutral and oxidized FFAs that induce endothelial cell inflammation. J Lipid Res. 2009;50:204–213. doi: 10.1194/jlr.M700505-JLR200.
    1. Weber-Hamann B, Kopf D, Lederbogen F, Gilles M, Heuser I, Colla M, Deuschle M, Deuschle M. Activity of the hypothalamus–pituitary–adrenal system and oral glucose tolerance in depressed patients. Neuroendocrinology. 2005;81:200–204. doi: 10.1159/000087003.
    1. WHO (2006) Constitution of the World Health Organization. In:
    1. Williams MA, Enquobahrie DA, Zimmer J, Qiu CF, Hevner K, Abetew D, Christianson C, Sheaff C. Maternal plasma advanced glycation end products concentrations in response to oral 50-gram glucose load in mid-pregnancy: a pilot study. Clin Lab. 2012;58:1045–1050.
    1. Wopereis S, Rubingh CM, van Erk MJ, Verheij ER, van Vliet T, Cnubben NH, Smilde AK, van der Greef J, van Ommen B, Hendriks HF. Metabolic profiling of the response to an oral glucose tolerance test detects subtle metabolic changes. PLoS One. 2009;4:e4525. doi: 10.1371/journal.pone.0004525.
    1. Wopereis S, Wolvers D, van Erk M, Gribnau M, Kremer B, van Dorsten FA, Boelsma E, Garczarek U, Cnubben N, Frenken L, van der Logt P, Hendriks HF, Albers R, van Duynhoven J, van Ommen B, Jacobs DM. Assessment of inflammatory resilience in healthy subjects using dietary lipid and glucose challenges. BMC Med Genomics. 2013;6:44. doi: 10.1186/1755-8794-6-44.
    1. Wu C, Yu Z (2004) Effects on blood glucose, insulin, lipid and proatherosclerotic parameters in stable type 2 diabetic subjects during an oral fat challenge. Lipids Health Dis 3:17
    1. Wuesten O, Balz CH, Bretzel RG, Kloer H, Hardt PD. Effects of oral fat load on insulin output and glucose tolerance in healthy control subjects and obese patients without diabetes. Diabetes Care. 2005;28:360–365. doi: 10.2337/diacare.28.2.360.
    1. Zhao X, Peter A, Fritsche J, Elcnerova M, Fritsche A, Häring H, Schleicher ED, Xu G, Lehmann R. Changes of the plasma metabolome during an oral glucose tolerance test: is there more than glucose to look at? Am J Physiol Endocrinol Metab. 2009;296:E384–E393. doi: 10.1152/ajpendo.90748.2008.
    1. Zwirska-Korczala K, Konturek SJ, Sodowski M, Wylezol M, Kuka D, Sowa P, Adamczyk-Sowa M, Kukla M, Berdowska A, Rehfeld JF, Bielanski W, Brzozowski T. Basal and postprandial plasma levels of PYY, ghrelin, cholecystokinin, gastrin and insulin in women with moderate and morbid obesity and metabolic syndrome. J Physiol Pharmacol. 2007;58:13–35.

Source: PubMed

3
Prenumerera